
65.86 Delayed Data As of Jun 09 | ![]() Today’s Change | 42.01 Today|||52-Week Range 66.56 | +24.45% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $5.9B |
Intra-Cellular Therapies, Inc. 430 East 29th Street New York New York 10016 |
Sharon Mates | Chairman, President & Chief Executive Officer |
Lawrence J. Hineline | Chief Financial Officer, Treasurer & SVP-Finance |
Robert E. Davis | Chief Scientific Officer & Senior Vice President |
Suresh Durgam | Chief Medical Officer & Senior Vice President |
Karen Patruno Sheehy | Chief Compliance Officer & Senior Vice President |